From the Financial Post:
Pfizer Inc. said yesterday the Federal Court of Appeal of Canada has blocked generic drugmaker Teva Pharmaceutical Industries Ltd. from launching a copycat form of its Celebrex arthritis drug in the country until 2014.
Pfizer said the court, in its ruling, reversed a lower court ruling that would have permitted Teva's Novopharm affiliate to launch its form of Celebrex in Canada.
The patent concerned the chemical composition of Celebrex, Pfizer spokesman Bryant Haskins said. ...more
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment